DI-TERT-BUTYL (2-HYDROXYETHYL)IMIDODICARBONATE, 95.0%, 250mg

(2S,4R)-4-Hydroxypyrrolidine-2-carboxylic acid hydrochloride, 95.0%, 5g

(S)-1-Methyl-piperidin-3-ylamine dihydrochloride, 97.0%, 5g

N-(3-Cyanophenyl)methanesulfonamide, 95.0%, 10g

8-benzyl-1-oxa-3,8-diazaspiro[4.5]decan-2-one, 97%, 1g

(R)-1-(3-Fluoropyridin-2-yl)ethan-1-ol, 1g

TERT-BUTYL 4-(3-NITROBENZYL)PIPERAZINE-1-CARBOXYLATE, 95.0%, 250mg

(2-CHLORO-PHENYL)-DIMETHYLAMINO-ACETIC ACID HCL, 95.0%, 250mg

Fmoc-3-amino-4-methoxy-benzoic acid, 99.0%, 1g

1,2-Dimyristoyl-sn-glycero-3-phosphocholine>97.0%(HPLC)(T)1g

(R)-tert-Butyl (1-hydrazinyl-1-oxopropan-2-yl)carbamate, 250mg

GC capillary column ROTI®Cap-5, 30 m, 0.25 mm, 1.00 µm, 1 Piece(s)

Copper(I) Trifluoromethanesulfonate Benzene Complex>90.0%(T)5g